Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease

Brain : a Journal of Neurology
Einat VitnerAnthony H Futerman

Abstract

Gaucher's disease, the most common lysosomal storage disorder, is caused by the defective activity of glucocerebrosidase, the lysosomal hydrolase that degrades glucosylceramide. The neuronopathic forms of Gaucher's disease are characterized by severe neuronal loss, astrocytosis and microglial proliferation, but the cellular and molecular pathways causing these changes are not known. In the current study, we delineate the role of neuroinflammation in the pathogenesis of neuronopathic Gaucher's disease and show significant changes in levels of inflammatory mediators in the brain of a neuronopathic Gaucher's disease mouse model. Levels of messenger RNA expression of interleukin -1β, tumour necrosis factor-α, tumour necrosis factor-α receptor, macrophage colony-stimulating factor and transforming growth factor-β were elevated by up to ∼30-fold, with the time-course of the increase correlating with the progression of disease severity. The most significant elevation was detected for the chemokines CCL2, CCL3 and CCL5. Blood-brain barrier disruption was also evident in mice with neuronopathic Gaucher's disease. Finally, extensive elevation of nitrotyrosine, a hallmark of peroxynitrite (ONOO(-)) formation, was observed, consistent with...Continue Reading

References

Feb 1, 1995·Molecular and Chemical Neuropathology·R WillemsenR C Mulligan
Aug 1, 1997·Blood Cells, Molecules & Diseases·C E HollakM H van Oers
Apr 30, 1999·Progress in Neurobiology·W J StreitN A Pennell
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·R WadaR L Proia
Oct 18, 2000·Journal of Neurochemistry·A V Andjelkovic, J S Pachter
Feb 2, 2002·Neuroscience·D C GermanJ M Dietschy
Feb 21, 2002·The Journal of Clinical Investigation·Ralph C Budd
Jun 5, 2002·Neuroimmunomodulation·L VitkovicE Sternberg
Feb 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro OhmiElizabeth F Neufeld
May 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yun-Ping Wu, Richard L Proia
Jul 6, 2004·Molecular Genetics and Metabolism·Kondi WongRaphael Schiffmann
Oct 7, 2004·Molecular Genetics and Metabolism·Ellen Sidransky
Oct 27, 2004·Annals of Neurology·Mylvaganam JeyakumarFrances M Platt
Feb 4, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Svetlana M StamatovicAnuska V Andjelkovic
Apr 9, 2005·British Journal of Haematology·Marina Jmoudiak, Anthony H Futerman
Aug 6, 2005·Progress in Neurobiology·Michelle L Block, Jau-Shyong Hong
Jun 27, 2006·European Journal of Clinical Investigation·N A C H Brabers, H S L M Nottet
Aug 8, 2006·Journal of Korean Medical Science·Young Bin HongSung-Chul Jung
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Aug 2, 2007·Nature Reviews. Drug Discovery·Csaba SzabóRafael Radi
Oct 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ida Berglin EnquistStefan Karlsson
May 15, 2008·Journal of Neuroinflammation·Christopher J HenryJonathan P Godbout
Oct 22, 2008·Progress in Brain Research·Gülgün Tezel
Feb 6, 2009·Human Molecular Genetics·Tamar Farfel-BeckerAnthony H Futerman
Jun 27, 2009·Immunopharmacology and Immunotoxicology·Rizwan AhmadHaseeb Ahsan
Jul 28, 2009·Neurobiology of Disease·David SmithFrances M Platt
May 1, 2010·The Journal of Biological Chemistry·Einat B VitnerAnthony H Futerman
Sep 3, 2010·Progress in Molecular Biology and Translational Science·Yu YamaguchiFumitoshi Irie
Oct 1, 2010·Blood Cells, Molecules & Diseases·N GuptaE Sidransky
Oct 5, 2010·Progress in Brain Research·Christopher J Barnum, Malú G Tansey
Nov 6, 2010·Archives of Pharmacal Research·Young-Jung LeeJin Tae Hong
May 3, 2011·PloS One·Ying SunGregory A Grabowski
May 28, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Tamar ShacharAnthony H Futerman
Jun 10, 2011·The Journal of Biological Chemistry·Thai Leong YapJennifer C Lee
Sep 29, 2011·Disease Models & Mechanisms·Tamar Farfel-BeckerAnthony H Futerman

❮ Previous
Next ❯

Citations

Apr 24, 2013·Journal of Inherited Metabolic Disease·N Joan Abbott
Jan 21, 2014·Nature Medicine·Einat B VitnerAnthony H Futerman
Mar 13, 2014·Biochimica Et Biophysica Acta·Hila ZigdonAnthony H Futerman
May 15, 2013·Cellular and Molecular Life Sciences : CMLS·Michela Deleidi, Thomas Gasser
Feb 20, 2016·Current Opinion in Cell Biology·Marielle S KöberlinGiulio Superti-Furga
Nov 21, 2014·Molecular Genetics and Metabolism·Elena L Aronovich, Perry B Hackett
Feb 28, 2016·Respiratory Physiology & Neurobiology·Sara M F TurnerDavid D Fuller
Oct 18, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Leslie L MuldoonEdward A Neuwelt
Mar 21, 2016·Journal of Neurology·Ivanka MarkovićVladimir S Kostić
Mar 8, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·John MarshallSeng H Cheng
Dec 3, 2014·Neuroscience·N DzamkoG M Halliday
Sep 19, 2014·Biochemical Society Transactions·Charles Shyng, Mark S Sands
Nov 25, 2014·Expert Opinion on Therapeutic Targets·Einat B VitnerAnthony H Futerman
Apr 17, 2016·Orphanet Journal of Rare Diseases·Ryan D GeraetsJill M Weimer
Jun 4, 2015·Neuroscience·K V Rama Rao, T Kielian
Jan 9, 2015·Brain : a Journal of Neurology·Carla MartinsAlexey V Pshezhetsky
May 14, 2016·Journal of Neuroinflammation·Einat B VitnerAnthony H Futerman
Aug 28, 2015·PloS One·Kazuyuki KitataniYusuf A Hannun
May 29, 2016·The Journal of Pathology·Ayelet VardiAnthony H Futerman
Jul 14, 2016·Brain & Development·Phedias DiamandisPatrick Shannon
Jul 28, 2016·Human Mutation·Mia HorowitzOzlem Goker-Alpan
Apr 22, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Axel SteinUlrich Matzner
May 19, 2017·Human Molecular Genetics·Federico N SoriaPierre-Olivier Fernagut
May 20, 2014·Journal of Lipid Research·Linda Ingemann, Thomas Kirkegaard
Jan 1, 2015·Journal of Experimental Neuroscience·Rob U Onyenwoke, Jay E Brenman
May 21, 2015·World Journal of Experimental Medicine·Andrea PredonzaniBarbara Molon
Feb 1, 2018·The FEBS Journal·Matthew E Gegg, Anthony H V Schapira
Dec 15, 2017·BMJ Case Reports·Rajveer SinghManoj Kumar Goyal
Dec 28, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Fabio BlandiniJosé L Lanciego
Jun 13, 2019·Current Opinion in Neurology·Emory RyanEllen Sidransky
Dec 12, 2018·The EMBO Journal·Enrique Gabandé-RodríguezMaría Dolores Ledesma
Sep 12, 2019·Journal of Clinical Medicine·Or CabassoMia Horowitz
Jan 18, 2018·British Journal of Neurosurgery·Matthew R ReynoldsJacques E Dion
Aug 25, 2020·Acta Neuropathologica Communications·Sharon MelamedEinat B Vitner
Feb 27, 2015·Biological Chemistry·Einat B VitnerNick Platt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.